Jiangsu Bioperfectus Technologies Co Ltd
 

« Previous article
Monkeypox Virus Real...

17th June 2022  Content supplied by: Jiangsu Bioperfectus Technologies Co., Ltd.

Bioperfectus Real-Time PCR Systems Included in FDA-listed for IVD Testing


Bioperfectus are proud to announce that STC-96A and STC-96A PLUS Real-Time PCR Systems have been listed with the U.S. Food and Drug Administration (FDA) for IVD testing. With FDA registration, Bioperfectus Real-Time PCR Systems obtained access to PCR laboratories in the US. With stable performance and user-friendly design, STC-96A and STC-96A Plus will be great helpers for molecular laboratories to identify the virus and bacteria.

Throughout the COVID-19 pandemic, Bioperfectus Real-Time PCR Systems with CE Mark have been distributed to over 100 PCR laboratories, molecular diagnostic centers, hospitals, and national laboratories worldwide since the product’s launch last November.

Besides STC-96A and STC-96A PLUS PCR system, our automated nucleic acid extraction workstation SAW-96, nucleic acid extraction system (SSNP-2000B/3000A/9600A, SMPE-960), and all extraction kits are also included in FDA-Listed for IVD Testing.

Bioperfectus One Solution, One Supplier, One Response (3 “Ones”) Total PCR Solution was introduced earlier this year with a strategy to provide the most advanced molecular diagnostic solution to laboratories worldwide with the fastest and most professional response.
For now, Bioperfecuts could provide products from nucleic acids extraction to PCR, from instruments to reagents as a Total PCR Solution supplier for U.S. laboratories.

Visit Bioperfectus or use the Request Information button below.


    

Tags:


Date Published: 17th June 2022

Source article link: View


View full company details